Cargando…
PEDF and VEGF-A Output from Human Retinal Pigment Epithelial Cells Grown on Novel Microcarriers
Human retinal pigment epithelial (hRPE) cells have been tested as a cell-based therapy for Parkinson's disease but will require additional study before further clinical trials can be planned. We now show that the long-term survival and neurotrophic potential of hRPE cells can be enhanced by the...
Autores principales: | Falk, Torsten, Congrove, Nicole R., Zhang, Shiling, McCourt, Alexander D., Sherman, Scott J., McKay, Brian S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323925/ https://www.ncbi.nlm.nih.gov/pubmed/22547925 http://dx.doi.org/10.1155/2012/278932 |
Ejemplares similares
-
The Yin and Yang of VEGF and PEDF: Multifaceted Neurotrophic Factors and Their Potential in the Treatment of Parkinson’s Disease
por: Falk, Torsten, et al.
Publicado: (2010) -
C3a Increases VEGF and Decreases PEDF mRNA Levels in Human Retinal Pigment Epithelial Cells
por: Long, Qin, et al.
Publicado: (2016) -
Cigarette Smoke-Related Hydroquinone Dysregulates MCP-1, VEGF and PEDF Expression in Retinal Pigment Epithelium in Vitro and in Vivo
por: Pons, Marianne, et al.
Publicado: (2011) -
Decreased VEGF-A and sustained PEDF expression in a human retinal pigment epithelium cell line cultured under hypothermia
por: Takeyama, Masayuki, et al.
Publicado: (2015) -
Vascular endothelial growth factor B (VEGF-B) is up-regulated and exogenous VEGF-B is neuroprotective in a culture model of Parkinson's disease
por: Falk, Torsten, et al.
Publicado: (2009)